Survival analyses of the ZeOxaNMulti trial: Follow-up randomized, double-blinded, placebo-controlled trial of oral PMA-zeolite to prevent chemotherapy-induced side effects, especially peripheral neuropathy

Following the previously published results of the clinical randomized ZeOxaNMulti trial, we evaluated the potential of the tested product PMA-ZEO (Multizeo Med) in the prevention of chemotherapy-induced side effects (especially peripheral neuropathy) within a 30-month follow-up analysis. The aim was...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitale, Maria Giuseppa, Crispo, Anna, Arundine, Dario, Ronga, Riccardo, Barbato, Carmela, Luongo, Assunta, Habetswallner, Francesco, De Martino, Bernardo Maria, Maione, Angela, Eisenwagen, Sandra, Vitale, Giovanna, Riccardi, Ferdinando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680527/
https://www.ncbi.nlm.nih.gov/pubmed/36425572
http://dx.doi.org/10.3389/fphar.2022.874028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680527/
https://www.ncbi.nlm.nih.gov/pubmed/36425572
http://dx.doi.org/10.3389/fphar.2022.874028

Ejemplares similares